These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


758 related items for PubMed ID: 19509143

  • 1. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.
    Rutella S, Bonanno G, Procoli A, Mariotti A, Corallo M, Prisco MG, Eramo A, Napoletano C, Gallo D, Perillo A, Nuti M, Pierelli L, Testa U, Scambia G, Ferrandina G.
    Clin Cancer Res; 2009 Jul 01; 15(13):4299-311. PubMed ID: 19509143
    [Abstract] [Full Text] [Related]

  • 2. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
    Rocco A, Liguori E, Pirozzi G, Tirino V, Compare D, Franco R, Tatangelo F, Palaia R, D'Armiento FP, Pollastrone G, Affuso A, Bottazzi EC, Masone S, Persico G, Nardone G.
    J Cell Physiol; 2012 Jun 01; 227(6):2686-93. PubMed ID: 21898409
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.
    Tirino V, Camerlingo R, Franco R, Malanga D, La Rocca A, Viglietto G, Rocco G, Pirozzi G.
    Eur J Cardiothorac Surg; 2009 Sep 01; 36(3):446-53. PubMed ID: 19464919
    [Abstract] [Full Text] [Related]

  • 7. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.
    Ma S, Tang KH, Chan YP, Lee TK, Kwan PS, Castilho A, Ng I, Man K, Wong N, To KF, Zheng BJ, Lai PB, Lo CM, Chan KW, Guan XY.
    Cell Stem Cell; 2010 Dec 03; 7(6):694-707. PubMed ID: 21112564
    [Abstract] [Full Text] [Related]

  • 8. [Sorting of CD133(+) subset cells in human gastric cancer and the identification of their tumor initiating cell-like properties].
    Lu RQ, Wu JG, Zhou GC, Jiang HG, Yu JW, Jiang BJ.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb 03; 15(2):174-9. PubMed ID: 22368028
    [Abstract] [Full Text] [Related]

  • 9. Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells.
    Friel AM, Zhang L, Curley MD, Therrien VA, Sergent PA, Belden SE, Borger DR, Mohapatra G, Zukerberg LR, Foster R, Rueda BR.
    Reprod Biol Endocrinol; 2010 Dec 01; 8():147. PubMed ID: 21122138
    [Abstract] [Full Text] [Related]

  • 10. A distinct subpopulation within CD133 positive brain tumor cells shares characteristics with endothelial progenitor cells.
    Choi SA, Wang KC, Phi JH, Lee JY, Park CK, Park SH, Kim SK.
    Cancer Lett; 2012 Nov 28; 324(2):221-30. PubMed ID: 22652175
    [Abstract] [Full Text] [Related]

  • 11. Isolation and characterization of proliferative, migratory and multidrug-resistant endometrial carcinoma-initiating cells from human type II endometrial carcinoma cell lines.
    Gao Y, Liu T, Cheng W, Wang H.
    Oncol Rep; 2012 Aug 28; 28(2):527-32. PubMed ID: 22581025
    [Abstract] [Full Text] [Related]

  • 12. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
    Choijamts B, Jimi S, Kondo T, Naganuma Y, Matsumoto T, Kuroki M, Iwasaki H, Emoto M.
    Stem Cells; 2011 Oct 28; 29(10):1485-95. PubMed ID: 21919130
    [Abstract] [Full Text] [Related]

  • 13. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.
    Kryczek I, Liu S, Roh M, Vatan L, Szeliga W, Wei S, Banerjee M, Mao Y, Kotarski J, Wicha MS, Liu R, Zou W.
    Int J Cancer; 2012 Jan 01; 130(1):29-39. PubMed ID: 21480217
    [Abstract] [Full Text] [Related]

  • 14. Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo.
    Tirino V, Desiderio V, Paino F, De Rosa A, Papaccio F, Fazioli F, Pirozzi G, Papaccio G.
    FASEB J; 2011 Jun 01; 25(6):2022-30. PubMed ID: 21385990
    [Abstract] [Full Text] [Related]

  • 15. Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.
    Chen KL, Pan F, Jiang H, Chen JF, Pei L, Xie FW, Liang HJ.
    Clin Exp Metastasis; 2011 Dec 01; 28(8):751-63. PubMed ID: 21750907
    [Abstract] [Full Text] [Related]

  • 16. CD133+CD44+ population efficiently enriches colon cancer initiating cells.
    Haraguchi N, Ohkuma M, Sakashita H, Matsuzaki S, Tanaka F, Mimori K, Kamohara Y, Inoue H, Mori M.
    Ann Surg Oncol; 2008 Oct 01; 15(10):2927-33. PubMed ID: 18663533
    [Abstract] [Full Text] [Related]

  • 17. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
    Haraguchi N, Ishii H, Mimori K, Ohta K, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Yamamoto H, Doki Y, Mori M.
    Int J Oncol; 2013 Aug 01; 43(2):425-30. PubMed ID: 23708747
    [Abstract] [Full Text] [Related]

  • 18. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.
    Ma L, Lai D, Liu T, Cheng W, Guo L.
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep 01; 42(9):593-602. PubMed ID: 20705681
    [Abstract] [Full Text] [Related]

  • 19. Characteristics of CD133(+) human colon cancer SW620 cells.
    Kawamoto H, Yuasa T, Kubota Y, Seita M, Sasamoto H, Shahid JM, Hayashi T, Nakahara H, Hassan R, Iwamuro M, Kondo E, Nakaji S, Tanaka N, Kobayashi N.
    Cell Transplant; 2010 Sep 01; 19(6):857-64. PubMed ID: 20587144
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 38.